P-bodies directly regulate MARF1-mediated mRNA decay in human cells

• Published in: Nucleic acids research Vol. 50; no. 13; pp. 7623 - 7636
• Main Authors: Brothers, William R, Fakim, Hana, Kajjo, Sam, Fabian, Marc R
• Format: Journal Article
• Language: English
• Published: Oxford University Press 22.07.2022
• Subjects: RNA and RNA-protein complexes
• ISSN: 0305-1048; 1362-4962
• DOI: 10.1093/nar/gkac557

Abstract Processing bodies (P-bodies) are ribonucleoprotein granules that contain mRNAs, RNA-binding proteins and effectors of mRNA turnover. While P-bodies have been reported to contain translationally repressed mRNAs, a causative role for P-bodies in regulating mRNA decay has yet to be established. Enhancer of decapping protein 4 (EDC4) is a core P-body component that interacts with multiple mRNA decay factors, including the mRNA decapping (DCP2) and decay (XRN1) enzymes. EDC4 also associates with the RNA endonuclease MARF1, an interaction that antagonizes the decay of MARF1-targeted mRNAs. How EDC4 interacts with MARF1 and how it represses MARF1 activity is unclear. In this study, we show that human MARF1 and XRN1 interact with EDC4 using analogous conserved short linear motifs in a mutually exclusive manner. While the EDC4–MARF1 interaction is required for EDC4 to inhibit MARF1 activity, our data indicate that the interaction with EDC4 alone is not sufficient. Importantly, we show that P-body architecture plays a critical role in antagonizing MARF1-mediated mRNA decay. Taken together, our study suggests that P-bodies can directly regulate mRNA turnover by sequestering an mRNA decay enzyme and preventing it from interfacing with and degrading targeted mRNAs.